These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36817584)

  • 1. Factors related to steroid treatment responsiveness in thyroid eye disease patients and application of SHAP for feature analysis with XGBoost.
    Park J; Kim J; Ryu D; Choi HY
    Front Endocrinol (Lausanne); 2023; 14():1079628. PubMed ID: 36817584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of thyroid-stimulating immunoglobulin in recent-onset symptomatic thyroid eye disease.
    Lai KKH; Aljufairi FMAA; Sebastian JU; Wei Y; Jia R; Chan KKW; Au EYL; Lee ACH; Ng CM; Yuen HKL; Yip WWK; Young AL; Cheng GPM; Tham CCY; Pang CP; Chong KKL
    Eur Thyroid J; 2024 Aug; 13(4):. PubMed ID: 38847819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid stimulating immunoglobulin concentration is associated with disease activity and predicts response to treatment with intravenous methylprednisolone in patients with Graves' orbitopathy.
    Hötte GJ; Kolijn PM; de Bie M; de Keizer ROB; Medici M; van der Weerd K; van Hagen PM; Paridaens D; Dik WA
    Front Endocrinol (Lausanne); 2024; 15():1340415. PubMed ID: 38577576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of extreme gradient boosting, light gradient boosting machine, and deep neural networks to evaluate the activity stage of extraocular muscles in thyroid-associated ophthalmopathy.
    Li Y; Ma J; Xiao J; Wang Y; He W
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):203-210. PubMed ID: 37773288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of thyroid-stimulating immunoglobulin as a biomarker of the activity of thyroid eye disease.
    Jeon H; Lee JY; Kim YJ; Lee MJ
    Eye (Lond); 2023 Feb; 37(3):543-547. PubMed ID: 35220401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Utility of a New Assay for Thyroid Stimulating Immunoglobulins in Graves' Disease and Thyroid Eye Disease.
    Stan MN; Algeciras-Schimnich A; Murthy V; Thapa P; Araki N
    Thyroid; 2022 Feb; 32(2):170-176. PubMed ID: 34714163
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical efficacy of thyroid-stimulating immunoglobulin detection for diagnosing Graves' disease and predictors of responsiveness to methimazole.
    Liu K; Fu Y; Li T; Liu S; Chen D; Zhao C; Shi Y; Cai Y; Yang T; Zheng X
    Clin Biochem; 2021 Nov; 97():34-40. PubMed ID: 34331946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extreme gradient boosting model to assess risk of central cervical lymph node metastasis in patients with papillary thyroid carcinoma: Individual prediction using SHapley Additive exPlanations.
    Zou Y; Shi Y; Sun F; Liu J; Guo Y; Zhang H; Lu X; Gong Y; Xia S
    Comput Methods Programs Biomed; 2022 Oct; 225():107038. PubMed ID: 35930861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease.
    Ko J; Kook KH; Yoon JS; Woo KI; Yang JW;
    BMJ Open; 2022 Jun; 12(6):e050337. PubMed ID: 35728893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum thyroid stimulating immunoglobulin linked to failure of first-line intravenous methylprednisolone monotherapy in moderate-to-severe thyroid eye disease.
    Zloto O; Rosset A; Priel A; Landau-Prat D; Cukierman-Yaffe T; Shavit R; Agmon-Levin N; Ben Simon GJ; Sagiv O
    Eye (Lond); 2024 Mar; 38(4):687-690. PubMed ID: 37821543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach.
    Sipkova Z; Insull EA; David J; Turner HE; Keren S; Norris JH
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):834-839. PubMed ID: 30103255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid eye disease presenting with superior rectus/levator complex enlargement.
    Wang Y; Mettu P; Broadbent T; Radke P; Firl K; Shepherd JB; Couch SM; Nguyen A; Henderson AD; McCulley T; McClelland CM; Mokhtarzadeh A; Lee MS; Garrity JA; Harrison AR
    Orbit; 2020 Feb; 39(1):5-12. PubMed ID: 31056988
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.
    Ponto KA; Diana T; Binder H; Matheis N; Pitz S; Pfeiffer N; Kahaly GJ
    J Endocrinol Invest; 2015 Jul; 38(7):769-77. PubMed ID: 25736545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab as steroid-sparing treatment of inflammatory-stage thyroid eye disease.
    Ayabe R; Rootman DB; Hwang CJ; Ben-Artzi A; Goldberg R
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):415-9. PubMed ID: 24978425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future Projections in Thyroid Eye Disease.
    Barbesino G; Salvi M; Freitag SK
    J Clin Endocrinol Metab; 2022 Aug; 107(Suppl_1):S47-S56. PubMed ID: 36346684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the Development of Orbitopathy in Graves Thyroidopathy Patients: The Potential Role of TSI Testing.
    Takakura A; Kirkeby K; Earle K; Silkiss RZ
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):369-72. PubMed ID: 25585304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
    Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
    J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of machine learning and Logistic regression model in predicting acute kidney injury after cardiac surgery: data analysis based on MIMIC-III database].
    Xiong W; Zhang L; She K; Xu G; Bai S; Liu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov; 34(11):1188-1193. PubMed ID: 36567564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creating machine learning models that interpretably link systemic inflammatory index, sex steroid hormones, and dietary antioxidants to identify gout using the SHAP (SHapley Additive exPlanations) method.
    Cao S; Hu Y
    Front Immunol; 2024; 15():1367340. PubMed ID: 38751428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel.
    Zloto O; Sagiv O; Priel A; Cukierman-Yaffe T; Tirosh A; Agmon-Levin N; Madgar S; Serlin T; Ben Simon G
    Graefes Arch Clin Exp Ophthalmol; 2021 Jul; 259(7):2009-2015. PubMed ID: 33528651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.